Choksi Laboratories Ltd.
Snapshot View

38.65 +1.00 ▲2.7%

25 November 2022, 04:01:00 PM
Volume: 214

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.choksilab.com
Market Cap 26.92 Cr.
Enterprise Value(EV) 61.10 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 3.77 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 10.26 Trailing Twelve Months Ending 2022-09
Industry PE 49.95 Trailing Twelve Months Ending 2022-09
Book Value / Share 26.18 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.48 Calculated using Price: 38.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.70 Cr. 6,965,263 Shares
FaceValue 10
Company Profile
Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.66%
1 Week
+0.13%
1 Month
-3.62%
3 Month
+38.78%
6 Month
+42.62%
1 Year
+84.93%
2 Year
+260.88%
5 Year
+75.68%
10 Year
+294.79%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.95 4.45 3.67 4.34 6.19 6.90 -17.57 -13.74 1.16
Return on Capital Employed (%) 9.42 9.39 7.32 8.41 10.49 10.14 -8.27 0.02 6.75
Return on Assets (%) 3.19 2.31 1.80 2.15 3.16 3.20 -6.53 -4.06 0.32

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 20 19 20 21 22 24 20 18 18 18
Non Curr. Liab. 8 6 9 5 7 18 29 31 30 29
Curr. Liab. 10 12 14 14 16 13 14 16 16 15
Minority Int.
Equity & Liab. 39 38 43 41 45 55 64 65 63 62
Non Curr. Assets 27 23 28 28 30 39 47 52 49 48
Curr. Assets 11 15 15 13 15 16 17 13 14 14
Misc. Exp. not W/O
Total Assets 39 38 43 41 45 55 64 65 63 62

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 20 22 22 29 31 34 28 26 30 34
Other Income 0 1 0 1 0 0 0 0 0 0
Total Income 20 23 22 30 32 34 28 26 30 34
Total Expenditure -16 -17 -17 -24 -25 -26 -25 -22 -21 -23
PBIDT 4 6 5 6 7 8 3 5 9 12
Interest -1 -2 -1 -1 -2 -2 -2 -3 -3 -3
Depreciation -2 -3 -3 -3 -3 -4 -5 -5 -5 -5
Taxation 0 -1 0 0 -1 -1 2 0 0 0
Exceptional Items -2
PAT 1 1 1 1 1 2 -4 -3 0 3
Adjusted EPS 2 1 1 1 2 2 -6 -4 0 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 4 2 7 7 6 7 3 6 8
Cash Fr. Inv. -3 -6 -1 -7 -2 -5 -10 -14 -8 -3
Cash Fr. Finan. 0 1 -1 1 -5 -1 2 11 2 -5
Net Change 0 -1 0 0 0 0 -1 0 0 0
Cash & Cash Eqvt 2 1 1 1 1 1 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 31.48 31.48 31.48 31.48 31.48 31.48 31.48 31.48 31.48
Public 68.52 68.52 68.52 68.52 68.52 68.52 68.52 68.52 68.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 23 Nov 2022
Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Pursuant to Regulation 23(9) of the SEBl (Listing Obligations & Disclosure Requirements) 2015 as amended vide SEBl (Listing Obligations and Disclosure Requirements) (Amendment) Regulations 2018 please find an enclosed note on Related Party Transactions on a consolidated basis for the Half-year ended 30th September 2022 drawn in accordance with applicable accounting standards
Sat, 12 Nov 2022
Results For The Quarter And Half Year Ended On 30Th September 2022
Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 We Wish to inform you that following business were transacted at the meeting of the Board of Directors of the Company held on Saturday the day of 12th November 2022 at the registered office of the Company situated at Survey No 9/1 Near Balaji Tulsiyana Industrial Estate Gram Kumedi Indore 452010 MP
Sat, 12 Nov 2022
Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 We Wish to inform you that following business were transacted at the meeting of the Board of Directors of the Company held on Saturday the day of 12th November 2022 at the registered office of the Company situated at Survey No 9/1 Near Balaji Tulsiyana Industrial Estate Gram Kumedi Indore 452010 MP

Technical Scans View Details >>

Fri, 25 Nov 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Choksi Laboratories Ltd.

What is Choksi Lab share price?

Can I buy Choksi Lab shares now?

What is the Market Cap of Choksi Lab?

What are the key metrics to analyse Choksi Lab?

What is the 52 Week High and Low of Choksi Lab?

What is the trend of Choksi Lab share price?